Vitamin D enhances erlotinib response in EGFR-mutant non-small cell lung cancer

被引：0
|
作者：
Shaurova, Tatiana
Shoemaker, Suzanne F.
Hershberger, Pamela A.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4674
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4674
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Neurological death in patients with EGFR-mutant non-small cell lung cancer.
    Ramotar, Matthew
    Barnes, Sierra
    Doherty, Mark
    Shultz, David Benjamin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] EGFR-mutant non-small cell lung cancer in Aberdeen, Scotland - Treatment and outcomes
    El-Shakankery, K.
    Steven, E.
    Clark, C.
    Stilwell, C.
    Kerr, K.
    Nicolson, M.
    LUNG CANCER, 2017, 103 : S35 - S36
  • [23] CARDIOVASCULAR EVENTS IN PATIENTS WITH EGFR-MUTANT NON-SMALL CELL LUNG CANCER ON OSIMERTINIB
    Peleg, Ariel
    Ibtida, Ishmam
    Liu, Jennifer
    Steingart, Richard
    Yu, Anthony
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3288 - 3288
  • [24] Radiomic Signature to Predict Outcomes in EGFR-Mutant Non-Small Cell Lung Cancer
    Minatta, J. N.
    Deza, D.
    Aineseder, M.
    Nunez, M. Mestas
    Mosquera, C.
    Lupinacci, L.
    Benitez, S.
    Seehaus, A.
    Luna, D.
    Beresnak, A.
    Diaz, F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1166 - S1166
  • [25] ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer
    Ana Ortega-Franco
    Shereen Rafee
    Oncology and Therapy, 2022, 10 : 13 - 22
  • [26] BIM expression in EGFR-mutant non-small cell lung cancer (NSCLC) patients (pts) treated with erlotinib in Colombia.
    Cardona, Andres F.
    Karachallou, Niki
    Drozdowskyj, Ana
    Gimenez Capitan, Ana
    Angel Molina-Vila, Miguel
    Arrieta, Oscar
    Carranza, Hernan
    Vargas, Carlos A.
    Otero, Jorge M.
    Rosell, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [27] Optimization of Dosing for EGFR-Mutant Non-Small Cell Lung Cancer with Evolutionary Cancer Modeling
    Chmielecki, Juliann
    Foo, Jasmine
    Oxnard, Geoffrey R.
    Hutchinson, Katherine
    Ohashi, Kadoaki
    Somwar, Romel
    Wang, Lu
    Amato, Katherine R.
    Arcila, Maria
    Sos, Martin L.
    Socci, Nicholas D.
    Viale, Agnes
    de Stanchina, Elisa
    Ginsberg, Michelle S.
    Thomas, Roman K.
    Kris, Mark G.
    Inoue, Akira
    Ladanyi, Marc
    Miller, Vincent A.
    Michor, Franziska
    Pao, William
    SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (90)
  • [28] Pulsed dosing of erlotinib for central nervous system (CNS) progression in EGFR-mutant non-small cell lung cancer (NSCLC)
    Jackman, David Michael
    Mach, Stacy L.
    Heng, Jennifer C.
    Rabin, Michael S.
    Barbie, David Allen
    Gandhi, Leena
    Marcoux, J. Paul
    Costa, Daniel Botelho
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Remarkable response to dacomitinib in a patient with leptomeningeal carcinomatosis due to EGFR-mutant non-small cell lung cancer
    Mizusaki, Shun
    Otsubo, Kohei
    Ninomiya, Toshifumi
    Arimura, Hidenobu
    Tsuchiya-Kawano, Yuko
    Inoue, Koji
    THORACIC CANCER, 2021, 12 (01) : 114 - 116
  • [30] Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
    Gen, Soei
    Tanaka, Ichidai
    Morise, Masahiro
    Koyama, Junji
    Kodama, Yuta
    Matsui, Akira
    Miyazawa, Ayako
    Hase, Tetsunari
    Hibino, Yoshitaka
    Yokoyama, Toshihiko
    Kimura, Tomoki
    Yoshida, Norio
    Sato, Mitsuo
    Hashimoto, Naozumi
    BMC CANCER, 2022, 22 (01)
12345